208 related articles for article (PubMed ID: 37865988)
21. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L; Bisogno T; Di Marzo V
Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
Tóth KF; Ádám D; Bíró T; Oláh A
Molecules; 2019 Mar; 24(5):. PubMed ID: 30845666
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the endocannabinoid system in osteoarthritis pain.
La Porta C; Bura SA; Negrete R; Maldonado R
Eur J Neurosci; 2014 Feb; 39(3):485-500. PubMed ID: 24494687
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoids in pain modulation.
Walker JM; Huang SM
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):235-42. PubMed ID: 12052039
[TBL] [Abstract][Full Text] [Related]
25. The endocannabinoid system in migraine: from bench to pharmacy and back.
Tassorelli C; Greco R; Silberstein SD
Curr Opin Neurol; 2019 Jun; 32(3):405-412. PubMed ID: 30883435
[TBL] [Abstract][Full Text] [Related]
26. [News about therapeutic use of Cannabis and endocannabinoid system].
Duran M; Laporte JR; Capellà D
Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
[TBL] [Abstract][Full Text] [Related]
27. The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications.
Wolf J; Urits I; Orhurhu V; Peck J; Orhurhu MS; Giacomazzi S; Smoots D; Piermarini C; Manchikanti L; Kaye AD; Kaye RJ; Viswanath O
Curr Pain Headache Rep; 2020 Jun; 24(7):35. PubMed ID: 32506272
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation.
van den Hoogen NJ; Harding EK; Davidson CED; Trang T
Front Neural Circuits; 2021; 15():816747. PubMed ID: 35069129
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?
Milligan AL; Szabo-Pardi TA; Burton MD
J Dual Diagn; 2020; 16(1):106-119. PubMed ID: 31596190
[TBL] [Abstract][Full Text] [Related]
30. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid system and multiple sclerosis.
Baker D; Pryce G
Curr Pharm Des; 2008; 14(23):2326-36. PubMed ID: 18781983
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans.
Chadwick VL; Rohleder C; Koethe D; Leweke FM
Curr Opin Psychiatry; 2020 Jan; 33(1):20-42. PubMed ID: 31714262
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
Karanian DA; Bahr BA
Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoids in depressive disorders.
Poleszak E; Wośko S; Sławińska K; Szopa A; Wróbel A; Serefko A
Life Sci; 2018 Nov; 213():18-24. PubMed ID: 30290188
[TBL] [Abstract][Full Text] [Related]
35. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
36. Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.
Bright U; Akirav I
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628337
[TBL] [Abstract][Full Text] [Related]
37. [Cannabinoids in pain medicine].
Karst M
Schmerz; 2018 Oct; 32(5):381-396. PubMed ID: 29881935
[TBL] [Abstract][Full Text] [Related]
38. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
39. The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma.
Ebrahimi N; Far NP; Fakhr SS; Faghihkhorasani F; Miraghel SA; Chaleshtori SR; Rezaei-Tazangi F; Beiranvand S; Baziyar P; Manavi MS; Zarrabi A; Nabavi N; Ren J; Aref AR
Environ Res; 2023 Jul; 228():115914. PubMed ID: 37062475
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic opportunities through modulation of the endocannabinoid system.
Makriyannis A; Mechoulam R; Piomelli D
Neuropharmacology; 2005 Jun; 48(8):1068-71. PubMed ID: 15885714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
